Petros Pharmaceuticals, Inc. PTPI
Set alert
0.00 USD 0.00 0.00%
At close · Oct 30
0.04 +0.04 +1,900.00%
After hours · Oct 30, 4:00 PM ET
0.002 Day range 0.0024
0.002 52-week range 0.024
- YTD
- -75.00%
- 1 year
- -90.00%
- Open
- 0.002
- Prev close
- 0.002
- Mkt cap
- 84.74K
- Vol
- 64.10K
- Avg vol
- 140.18K
- EPS
- 0.08
- P/E
- 0.03
- Div yield
- 0.00%
More statistics
- Low
- 0.002
- High
- 0.0024
- Forward P/E
- -0.26
- Beta
- 2.28
- Short ratio
- 0.72
- Inst. own
- 2.29%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.32284
- 200-d avg
- 0.5288
- 1y target
- 0.00
6M chart
Signals (40)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| MACD: Sell Signal | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Sep 30, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 30, 2026 | 1 month ago |
| SMA: Bullish | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Sep 25, 2026 | 1 month ago |
| SMA: Bullish | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 4, 2026 | 1 month ago |
| RSI: Overbought | Sep 4, 2026 | 1 month ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 26, 2026 | 2 months ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| RSI: Overbought | Aug 25, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 12, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 31, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 30, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 21, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 20, 2026 | 3 months ago |
| RSI: Oversold | Jul 14, 2026 | 3 months ago |
| RSI: Oversold | Jun 30, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 17, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 9, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 9, 2026 | 4 months ago |
| SMA: Bearish | May 21, 2026 | 5 months ago |
| SMA: Bullish | May 8, 2026 | 5 months ago |
| SMA: Bearish | May 7, 2026 | 5 months ago |
| SMA: Bearish | May 7, 2026 | 5 months ago |
| MACD: Sell Signal | May 7, 2026 | 5 months ago |
| SMA: Bullish | May 6, 2026 | 5 months ago |
| MACD: Buy Signal | May 6, 2026 | 5 months ago |
| SMA: Bullish | May 5, 2026 | 6 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| MACD: Sell Signal | May 4, 2026 | 6 months ago |
Key statistics
- Market cap
- 2.85M
- Enterprise value
- 3.99M
- Trailing P/E
- 0.00
- Forward P/E
- -0.26
- PEG ratio
- 0.00
- Price / sales
- 0.69
- Price / book
- 0.07
- EPS (TTM)
- -3.80
- Beta
- 2.28
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -171.24%
- Revenue (TTM)
- 4.12M
- Revenue growth
- -28.70%
- Free cash flow
- -4.10M
- Total cash
- 7.46M
- Total debt
- 7.74M
- Return on equity
- -63.77%
- Shares outstanding
- 10.01M
- Short % of float
- 2.19%
- 50-day average
- 0.32284
- 200-day average
- 0.5288
Analyst view
Consensus: none
Price target (mean) 0.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
PTPI Revenue — quarterly 0
PTPI Net income — quarterly -2.26M
PTPI EPS — quarterly -9.37
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | 0.00 | -0.53 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -0.37 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -2.05 | — | — |
| Apr 1, 2024 | Dec 1, 2023 | 0.00 | -2.17 | — | — |
| Nov 15, 2023 | Sep 1, 2023 | 0.00 | -2.31 | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | -1.20 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 8, 2023 | Maxim Group | init | — | Buy |
About Petros Pharmaceuticals, Inc.
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease. The company offers men's health products, including vacuum erection devices, penile injections, PreBoost, VenoSeal, and urinary tract infection tests for the treatment of erectile dysfunction. Petros Pharmaceuticals, Inc. is based in New York, New York.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- petrospharma.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on PTPI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BERNSTEIN BRUCE T. | Director | Conversion of Exercise of derivative security | Apr 25, 2023 | 8,346 |
| BOCTOR FADY | Officer | Stock Award(Grant) | Dec 20, 2023 | 49,645 |
| BRADLEY GREG | Director | Conversion of Exercise of derivative security | Apr 25, 2023 | 8,314 |
| SILVERMAN JOSHUA N. | Director | Conversion of Exercise of derivative security | Apr 25, 2023 | 11,237 |
| WALKER WAYNE REMELL | Director | Conversion of Exercise of derivative security | Apr 25, 2023 | 8,314 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| UBS Group AG | 0.44% | 44,221 | 12.59K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.37% | 37,517 | 10.68K | Sep 29, 2024 |
| Vanguard Group Inc | 0.32% | 31,811 | 9.05K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.32% | 32,284 | 9.19K | Sep 29, 2024 |
| Blackrock Inc. | 0.16% | 16,128 | 4.59K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.03% | 3,255 | 926 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.35% | 35,024 | 9.97K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.32% | 31,811 | 9.05K | Sep 29, 2024 |
| Fidelity Series Total Market Index Fund | 0.01% | 1,160 | 330 | Oct 30, 2024 |